1. Show article details.

    Apple price target lifted at J.P. Morgan on optimism for iPhone SE in India

    MarketWatch – 8:31 AM ET 05/28/2020

    Morgan analyst Samik Chatterjee lifted his price target on Apple Inc.' s stock to $365 from $350 on Thursday, writing of his optimism for the lower-cost iPhone SE's potential in emerging markets. "Apple (AAPL) has struggled to date to build a material presence in India on account of premium price positioning as well as other drivers," he wrote, but the iPhone SE could be a "panacea" for Apple's (AAPL) problems in the country. "We estimate if Apple (AAPL) were able to capture roughly half of the 30 million to 35...

  2. Apple stock price target raised to $365 from $350 at J.P. Morgan

    MarketWatch – 6:44 AM ET 05/28/2020
  3. Show article details.

    Taiwan sees 2020 GDP slowing to 5-year low as pandemic hurts consumption

    Reuters – 4:51 AM ET 05/28/2020

    * 2020 growth now seen at 1.67%, vs previous forecast 2.37% * Q1 y/y growth revised up to 1.59%, from 1.54% * Coronavirus outbreak a major uncertainty ahead - stats office. By Yimou Lee and Roger Tung.

  4. Show article details.

    PRESS DIGEST - Wall Street Journal - May 28

    Reuters – 3:51 AM ET 05/28/2020

    The following are the top stories in the Wall Street Journal. - News Corp (NWSA) said it would stop printing more than 100 Australian newspapers by the end of June and switch most of its titles to digital-only publications, in its latest response to changes in media accelerated by the coronavirus pandemic. https://on.wsj.com/2M4tlYB.

  5. Show article details.

    Physitrack’s Patient Engagement Solution Achieves CE Marking as Medical Device

    Business Wire – 1:00 AM ET 05/28/2020

    Physitrack is pleased to announce it has achieved CE marking as a Medical Device Class I. This means that Physitrack’s Patient Engagement solution is compliant with the relevant standards and meets the requirements of the Medical Directives put in place by the European Union for the categorisation of software as medical devices.

  6. Show article details.

    Apple Lands Martin Scorsese Movie Starring Leonardo DiCaprio and Robert DeNiro -- 2nd Update

    DJ Business News – 10:27 PM ET 05/27/2020

    Apple Inc. (AAPL) has nabbed director Martin Scorsese's next film, "Killers of the Flower Moon," starring Leonardo DiCaprio and Robert De Niro, according to people familiar with the matter. The project will be Apple's (AAPL) biggest foray into film yet as it beat out other interested companies, including Netflix Inc., which produced Mr. The film will be labeled an Apple Original Film, and Paramount Pictures, which was the original home for the movie, will distribute the movie theatrically.

  7. Show article details.

    Apple secures deal for Scorsese's next film starring DiCaprio, De Niro -media

    Reuters – 9:50 PM ET 05/27/2020

    Apple Inc (AAPL) has secured a deal for Hollywood veteran Martin Scorsese's next film, "Killers of the Flower Moon," U.S. media reported on Wednesday, citing sources. "Killers of the Flower Moon" will star Leonardo DiCaprio and Robert De Niro.

  8. Show article details.

    Apple Lands Martin Scorsese Movie Starring Leonardo DiCaprio and Robert DeNiro -- Update

    DJ Business News – 8:11 PM ET 05/27/2020

    Apple Inc. (AAPL) has nabbed director Martin Scorsese's next film, "Killers of the Flower Moon," starring Leonardo DiCaprio and Robert De Niro, according to people familiar with the matter. The project will be the tech giant's biggest foray into film yet as it beat out other interested companies, including Netflix Inc., which produced Mr. The film will be labeled an Apple Original Film, and Paramount Pictures, which was the original home for the movie, will distribute the movie theatrically.

  9. Show article details.

    Apple Lands Martin Scorsese Movie Starring Leonardo DiCaprio and Robert DeNiro

    DJ Business News – 7:54 PM ET 05/27/2020

    Apple Inc. (AAPL) has nabbed director Martin Scorsese's next film, "Killers of the Flower Moon," starring Leonardo DiCaprio and Robert De Niro, according to people familiar with the matter. The project will be the tech giant's biggest foray into film yet as it beat out other interested companies, including Netflix Inc., which produced and. The film will be labelled an Apple Original Film, and Paramount Pictures, which was the original home for the movie, will distribute the movie...

  10. Show article details.

    MEDIA-Apple lands Martin Scorsese movie starring Leonardo DiCaprio and Robert DeNiro - WSJ

    Reuters – 7:43 PM ET 05/27/2020

    -- Source link: https://on.wsj.com/2zsEXSH. -- Note: Reuters has not verified this story and does not vouch for its accuracy.

  11. Show article details.

    BRIEF-Leidos Holdings Awarded Payment From Virnetx Lawsuit Against Apple Inc

    Reuters – 7:13 PM ET 05/27/2020

    Leidos Holdings Inc (LDOS): * LEIDOS AWARDED PAYMENT FROM VIRNETX, INC. LAWSUIT AGAINST APPLE INC. * APPLE HAS INDICATED THAT IT WILL SEEK RESTITUTION OF ITS PAYMENT TO VIRNETX IF RELIEF IS AWARDED. * SECOND CASE BY VIRNETX AGAINST APPLE IS STILL PENDING AT FEDERAL TRIAL COURT IN EASTERN DISTRICT OF TEXAS.

  12. Show article details.

    Apple is reopening more stores, but online progress also sparks optimism

    MarketWatch – 6:15 PM ET 05/27/2020

    At least three analysts raise their price targets on Apple's (AAPL) stock, pointing to positive signs across retail channels. Apple Inc. (AAPL) is slowly reopening more of its stores in what one analyst calls a "sign of improving trends," but the company seemed to be making strides in the "new normal" even before this move. At least three analysts chimed in with increasingly upbeat views of Apple's (AAPL) stock following Tuesday's reopening announcement, cheering progress in both online and offline...

  13. Show article details.

    French contact-tracing app approved by lawmakers, to launch this weekend

    Reuters – 2:25 PM ET 05/27/2020

    The French government's contact-tracing app project was approved by the lower house of parliament on Wednesday, paving the way for a weekend launch of a tool developed independently of the more widely used Apple/Google platform. Countries are rushing to develop smartphone apps as a way to help keep the novel coronavirus epidemic in check while reopening the economy.

  14. Show article details.

    French contact-tracing app plan approved by lower house of parliament

    Reuters – 1:19 PM ET 05/27/2020

    The French government's contact-tracing app project was approved by the lower house of parliament on Wednesday, paving the way for a launch over the weekend. The plan for the so-called "StopCovid" app, which had caused frictions even within President Emmanuel Macron's parliament majority because of privacy concerns, was approved by 338 MPs versus 215.

  15. Show article details.

    Apple passes Microsoft into 1st place on list of largest U.S. companies

    MarketWatch – 10:22 AM ET 05/27/2020

    Shares of Apple Inc. (AAPL) rose 0.2% in morning trading Wednesday, enough for the technology giant to leapfrog Microsoft Corp. (MSFT) into first place on the list of largest U.S. companies by market capitalization, for the first time in three months. Apple's (AAPL) stock price rose 65 cents, which raised Apple's (AAPL) market cap by $2.82 billion to $1.376 trillion. Meanwhile, shares of Microsoft (MSFT) fell $2.68, or 1.5%, to lower the software and cloud giant's market cap down by $20.32 billion to $1.357 trillion.

  16. Apple stock price target raised to $340 from $320 at BofA Securities

    MarketWatch – 9:58 AM ET 05/27/2020
  17. Show article details.

    Apple gets two price target boosts as store reopenings are a 'sign of improving trends'

    MarketWatch – 8:21 AM ET 05/27/2020

    Deutsche Bank analyst Jeriel Ong raised his price target on Apple Inc.' s stock to $320 from $305 Wednesday, writing of increased optimism now that Apple (AAPL) plans to reopen dozens of U.S. stores. The company announced in mid-March that it would be temporarily closing all of its stores outside China due to the pandemic. "We see store reopenings as a directional sign of improving trends and a drift toward a more normalized demand environment for Apple," Ong wrote.

  18. Apple stock price target raised to $320 from $305 at Deutsche Bank

    MarketWatch – 6:46 AM ET 05/27/2020
  19. Show article details.

    AT&T launches HBO Max, vying with Netflix, others for quarantine viewing

    Reuters – 6:00 AM ET 05/27/2020

    AT&T’s WarnerMedia division launches its HBO Max streaming service on Wednesday, taking on Netflix (NFLX), Disney and Amazon (AMZN) at a time when coronavirus lockdowns have boosted demand for streaming even as rising unemployment has cut disposable incomes. HBO Max launches to a captive audience stuck at home without access to theater, live music, shopping excursions or live or televised sporting events.

  20. Show article details.

    India makes source code of contact-tracing app public

    Reuters – 4:32 PM ET 05/26/2020

    India said on Tuesday it was making public the source code of its coronavirus contact-tracing app Aarogya Setu for Google's Android smartphones, a move digital rights activists said will boost the security of users.

Page:

Today's and Upcoming Events

  • Jul
    28

    AAPL to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • May
    08

    AAPL ex-Dividend for $0.82 on 05/08/2020

    • Announce Date: 04/30/2020
    • Record Date: 05/11/2020
    • Pay Date: 05/14/2020
  • Apr
    30

    AAPL announced Q2 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.